Market growth is primarily driven by the growing incidence of peripheral vascular diseases, growing geriatric population, and increasing preference for minimally invasive surgeries.
The global peripheral vascular devices market is segmented by type and region. By type, the peripheral vascular devices market is segmented into angioplasty balloons, angioplasty stents, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, and other peripheral vascular devices. The angioplasty stents segment is estimated to account for the largest market of the global peripheral vascular devices market in 2017.
The hemodynamic flow alteration devices market is further classified into embolic protection devices and chronic total occlusion devices. The embolic protection devices segment is estimated to account for the largest share of the global hemodynamic flow alteration devices market. The large share of this segment can be attributed to the increasing number of peripheral vascular surgeries.
The global peripheral vascular devices market is dominated by North America, followed by Europe. North America will continue to dominate the global peripheral vascular devices market in the forecast period, however, Asia Pacific is expected to witness the highest CAGR, with the growth in this market centered on Japan, China, and India. Factors such as the rising focus of major players in emerging Asia Pacific countries and government support is driving the growth of the peripheral vascular devices market in this region.
Medtronic (US), Boston Scientific (US), Abbott Laboratories (US), Terumo (Japan), Cordis (US), B. Braun (Germany), C.R. Bard (US), Biosensors (Singapore), and BIOTRONIK (Germany) have been identified as key players in peripheral vascular devices market.
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly